{
    "nctId": "NCT05974150",
    "briefTitle": "Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring",
    "officialTitle": "Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer, Acute Myelogenous Leukemia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Create Data Set",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All participants must be 18 years of age or older.\n* Subjects may be any stage and anywhere in the treatment continuum.\n* Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.\n* Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.\n* All participants must be able to understand English.\n\nExclusion Criteria:\n\n* Any patient who cannot understand written or spoken English.\n* Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.\n* Any patient on a treatment clinical trial.\n* Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}